Change of Name

Recorded: 2006-07-03 Pages: 4

Assignor

SYN X PHARMA INC.

Executed: 2006-02-09

Assignee

NANOGEN POINT OF CARE INC.

1 MARMAC DRIVE, TORONTO, ONTARIO, M9W 1E7, CANADA

Covered Property (1)

Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins

Application: 10/950,221 →

Publication: US 2005/0130245

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.